News Archive 2009
October 2009

30 October 2009
Hanseatic India Colloquium: Healthcare, Biotechnology and Pharmaceutical Sciences

 

 

The Fourth Hanseatic India Colloquium show-cased the progress that India has made in the field of life sciences and provided a platform for an effective networking between Indian and German/European companies. The emphasis was to catalyse an effective two way co-operation in the area of pharmaceuticals, biotechnology and healthcare. German and Indian decision-makers from the biotechnology, pharmaceutical and healthcare sectors were brought together, offering excellent networking opportunities. The interesting and fruitful programme was rounded out by a Networking Reception at the Hotel Hafen Hamburg.

The Fourth Hanseatic India Colloquium was again part of the India Week Hamburg.

Organisers: Dr. Amal Mukhopadhyay, ELGA Biotech, Dieter Grützmacher, MCC Administration GmbH, HWF Hamburg Business Development Corporation, NORGENTA

Partners in the organisation: Consul General of India, Hamburg, HWF Hamburg Business Development Corporation, ELGA Biotech, MCC Administration GmbH, Norgenta, Richard Schulte Consult

A brief Report
Pictures of the Colloquium
Special thanks to our sponsors
Presentations
Global trends in the Life Sciences Industry: Challenges of recent financial crisis
Dr. Siegfried Bialojan, Executive Director, Head European Life Science Centre, Ernst & Young GmbH, Mannheim, GERMANY

Opportunities and Challenges in Emerging Markets and Developing Countries
Dr. Jens, Würthner, Director, Translational Research Pharmacology & Discovery Medicine of GlaxoSmithKline, Stevenage, UK

Multi-source Pharmaceutical products: how India can help
Dr. Ashok Rattan, CEO, Fortis Clinical Research Ltd. (FCRL), Sunflag Hospital & Research Center, Faridabad (Haryana), INDIA

Generic Formulation Development: Germany-India case study
Mr. Sisir Gupta, COO, Venus Pharma GmbH, Werne, Germany and Chandigarh, INDIA

SPECIAL LECTURE
Micro-Insurance in Healthcare Sector: A pilot project of Allianz in India
Mr. Michael Anthony, Group Social Opportunities, Allianz SE, Munich, GERMANY

Strategic approach for development of modern herbal medicine: The Role of Indian medicinal plants
Dr. Sangeeta Banerji, Research Associate, Plantachem GbR, Berlin, Germany

Future prospects of Herbal Biotechnology – Role of KIIT-TBI
Dr. Mrutyunjay Suar, Director & Head, KIIT School of Biotechnology, Bhubaneswar, INDIA

Partnering models for effective molecular assay design and validation
Mr. Sanjay Bettadpura, Chief Business Development Officer, Polyclone Bioservices Pvt. Ltd., Bangalore, INDIA

Biosimilars: Indo-German cooperation in Technology Transfer
Dr. Michael Piontek, Managing Director, ARTES Biotechnology GmbH, Langenfeld, GERMANY
Combination of European and Indian Research Groups at Evotec
Dr. Klaus Maleck, CFO, Evotec AG, Hamburg, GERMANY
Bringing pharmaceutical compliance to pharmaceutical companies - Experiences in India
Mr. Florian Grabow, Sales and Business Consulting, Werum Software & Systems AG, Lüneburg, GERMANY
Recent Trends in European Patenting – Relevance to Indian Applicants
Dr. Ralf D. Kirsch, Biologist and Patent Attorney, GLAWE DELFS MOLL, Hamburg, GERMANY
Recent Trends in the Indian Patent Law
Mrs. Sunita Sreedharan, Patent Attorney, Chief Executive Officer, SKS Law Associates, New Delhi, INDIA

The role of Media in the growth of Life Sciences Industry in India
Mrs. Viveka Roychowdhury, Editorial Head, Express Pharma, Indian Express Newspapers (Mumbai) Ltd., Mumbai, INDIA

   
May 2009

INDO-GERMAN LIFE SCIENCE NETWORK
organised through the Association of German Biotech Companies, VBU
VBU-WEBINARE: Life Sciences - Access to the Indian Market
Monday, May 25: The Indian Life Sciences Market: Overview
Dr. Amal Mukhopadhyay delivered a lecture on
“Research & Development in Life Sciences: Opportunities in Indo-German Cooperation”

 
April 2009

Dr. Mukhopadhyay participated and presented a lecture at the high-level meeting entitled
“ Workshop: Entering Indian Market (Marktzugang Indien
für Medizintechnik, Pharma und Biotech)"
organised by Bayern Innovative and Med Tech Pharma e.V. in Nürnberg und Innsbruck during April 28-30, 2009
(www.medtech-pharma.de). The title of his lecture was “Research and Development in India: Opportunities for an efficient Indo-German Cooperation (Forschung und Entwicklung in Indien - Chancen für effiziente Kooperationsprojekte)".

 

 

News Archive 2008

   
 
   
© 2007-2017 ELGA BIOTECH All rights reserved